Skin cancer screening made easy via app
Skinscreener is your essential tool for proactive skin cancer prevention. With personalized insights and easy-to-use features, safeguarding your skin has never been simpler.
Medical Device
product
Skinscreener is your essential tool for proactive skin cancer prevention. With personalized insights and easy-to-use features, safeguarding your skin has never been simpler.























Employees can use SkinScreener anytime and anywhere, making regular skin checks easier to integrate into everyday life.
As a Class IIa medical device, SkinScreener provides an AI-based risk assessment of skin lesions directly via smartphone.
SkinScreener helps businesses strengthen prevention, raise awareness and expand their occupational health offering.
SkinScreener makes skin cancer prevention more accessible in everyday life, whether users notice a suspicious skin change for the first time or want to stay on top of regular skin checks.
Developed in close collaboration with medical experts, SkinScreener provides a user-friendly digital solution for an AI-based risk assessment of skin lesions, anytime and anywhere.
SkinScreener is a certified Class IIa medical device under MDR and enables users to assess suspicious skin changes quickly and easily via smartphone.
- Dr. Michael Tripolt
.webp)
SkinScreener is a CE-certified Class IIa medical device that supports users with a smartphone-based risk assessment of skin lesions.

Recognizes both pigmented and unpigmented skin cancers, including melanoma.

Protecting skin health across 17+ countries with over 300,000 downloads.

CE-certified Class IIa medical device – trusted by healthcare professionals worldwide.

Set monthly reminders and easily track skin changes over time with historical records.

Verified by clinical studies at Medical University of Graz – detects 95% of relevant skin tumors.

Capture a photo with your smartphone and receive an AI-powered risk assessment in seconds.
Over half a million skin images checked, 300.000 users reached, across 17 countries.